Coralyne analogs as topoisomerase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 455/03 (2006.01) A61K 31/47 (2006.01) C07D 217/16 (2006.01) C07D 217/24 (2006.01) C07D 405/04 (2006.01) C07D 491/04 (2006.01) C07D 491/14 (2006.01) C07D 491/147 (2006.01)

Patent

CA 2241551

The present invention provides protoberberine alkaloid derivatives useful as anticancer agents, and methods of use thereof. The invention also provides protoberberine derivatives useful as topoisomerase inhibitors. The invention further provides coralyne and nitidine derivatives which are topoisomerase I- targeted therapeutics effective against camptothecin resistant cancer cells, and are especially effective against CNS tumors.

L'invention concerne des dérivés d'alcaloïde de protoberbérine utiles en tant qu'agents anti-cancer, ainsi que leurs procédés d'utilisation. Elle concerne également des dérivés de protoberbérine utiles en tant qu'inhibiteurs de topoisomérase. Elle concerne encore des dérivés de coralyne et de nitidine qui sont des agents thérapeutiques dirigés contre la topoisomérase I et efficaces contre les cellules cancéreuses résistant à la camptothécine, ainsi que, particulièrement, contre les tumeurs du système nerveux central.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Coralyne analogs as topoisomerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Coralyne analogs as topoisomerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coralyne analogs as topoisomerase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1951909

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.